4-(4-(PYRIMIDIN-2-YL)PIPERAZIN-1-YL)BUTYL (1-(2-OXO-2-((4-(4-(PYRIMIDIN-2-YL)PIPERAZIN-1-YL)BUTYL)AMINO)ETHYL)CYCLOPENTYL)ACETATE
UNII CTI4QD21VS
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl (1-(2-oxo-2-((4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)amino)ethyl)cyclopentyl)acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CTI4QD21VS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2512210-24-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C33H51N9O3 YXYDLJHJUQFMCG-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl (1-(2-oxo-2-((4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)amino)ethyl)cyclopentyl)acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.